Found 10 dm-infectious-diseases trials
A listing of dm-infectious-diseases medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This clinical research trial is being conducted to find out whether the administration of two investigational dMab products (not approved by the US FDA) with an investigational device is safe, tolerated, and can produce enough antibodies in your blood that may indicate the ability to prevent infection of COVID-19.
If you tested positive for COVID-19 within the last 5 days, you may be eligible to participate in a research study to test the ability of a pill to reduce COVID-19 symptoms.
The main purpose of this study is to learn if a vaccine that is given as two shots (injections) to prevent spinal meningitis (an infection of the lining of the brain and spinal cord caused by Neisseria meningitidis type B) might also work in preventing gonorrhea (caused by Neisseria gonorrhoeae). …
The research study is being conducted to assess the role of Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) imaging (a radiology scan) for monitoring the course of COVID-19 infection.
Some samples (for example, blood, tissue, fluids) taken from you during this or another research study might be useful for research at some later date. This study is being done so that your samples can be stored and used at some later date for research studies, including genetic testing. These …
PRIMARY OBJECTIVE: To demonstrate that treatment of Invasive Candidiasis/ Candidemia with IV echinocandin followed by oral ibrexafungerp is non-inferior to IV echinocandin followed by oral fluconazole based on 30-day all-cause mortality (ACM). SECONDARY OBJECTIVES: To demonstrate that treatment of Invasive Candidiasis/ Candidemia with intravenous (IV) echinocandin followed by oral ibrexafungerp …
This study will test an experimental drug named Lenacapavir (LEN), also known as Sunlenca® for the prevention of HIV-1 infection. The other HIV and pre-exposure prophylaxis (PrEP) medication included in this study is F/TDF (brand name Truvada®) which contains emtricitabine (F) and tenofovir disoproxil fumarate (TDF). F/TDF is approved for …
A trial to compare different investigational agents for their ability to improve clinical outcomes n severely ill patients with COVID-19 pneumonia.
The purpose of this study is to look at where human immunodeficiency virus (HIV) might be “hiding” when standard lab tests show that HIV levels in the blood are very low.
Please refer to protocol section 3 for information on study objectives. Overall objectives include: Objective 1: Determine the efficacy of letermovir for preventing CMV infection in thoracic organ transplant recipients as compared to valganciclovir prophylaxis Objective 2: Determine the tolerability of letermovir for CMV prophylaxis among heart and lung transplant …
